{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:17:37Z","timestamp":1768529857644,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"am","delay-in-days":407,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.nmd.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,2,23]],"date-time":"2020-02-23T01:18:17Z","timestamp":1582420697000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A late-onset congenital myasthenic syndrome due to a heterozygous DOK7 mutation"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-3611","authenticated-orcid":false,"given":"Paulo","family":"Bastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-2975","authenticated-orcid":false,"given":"Raquel","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-1974","authenticated-orcid":false,"given":"Marco","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.02.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2020.02.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of musk antibodies in seronegative myasthenia gravis","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2020.02.009_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000427","article-title":"Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission","volume":"9","author":"M\u00fcller","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.nmd.2020.02.009_bib0004","doi-asserted-by":"crossref","DOI":"10.3233\/JND-150098","article-title":"Congenital myasthenic syndromes with predominant limb girdle weakness","author":"Evangelista","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2020.02.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/ana.410110603","article-title":"A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2020.02.009_bib0006","article-title":"Kongenitale myasthene syndrome im erwachsenenalter","author":"Wunderlich","year":"2018","journal-title":"Nervenarzt"},{"key":"10.1016\/j.nmd.2020.02.009_bib0007","first-page":"25","article-title":"Dok-7\/MuSK signaling and a congenital myasthenic syndrome","volume":"27","author":"Yamanashi","year":"2008","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol"},{"key":"10.1016\/j.nmd.2020.02.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/dds198","article-title":"The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome","author":"Cossins","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2020.02.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2009.177816","article-title":"Molecular characterisation of congenital myasthenic syndromes in southern Brazil","author":"Mihaylova","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2020.02.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","author":"M\u00fcller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.02.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nmd.2020.02.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","author":"Selcen","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2020.02.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00015.2011","article-title":"End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease","author":"Sine","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2020.02.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and dok-7 myasthenia","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.02.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(96)00894-3","article-title":"Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol","author":"Milone","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.nmd.2020.02.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of \u03b2-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","author":"Lynch","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2020.02.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0914087107","article-title":"Myosin Va cooperates with PKA RI\u03b1 to mediate maintenance of the endplate in vivo","author":"R\u00f6der I","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2020.02.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz059","article-title":"Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome","author":"McMacken","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2020.02.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000061483.11417.1B","article-title":"Treatment of slow-channel congenital myasthenic syndrome with fluoxetine","author":"Harper","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.02.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.94.5.2041","article-title":"Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)","author":"Garc\u00eda-Colunga","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2020.02.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2017.12.005","article-title":"DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine","author":"Santos","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.02.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.02.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M708607200","article-title":"Mutations causing DOK7 congenital myasthenia ablate functional motifs in DOK-7","author":"Hamuro","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2020.02.009_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2020.02.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000152","article-title":"Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes","author":"Azuma","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.nmd.2020.02.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2010.081034","article-title":"Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing","author":"Gaudon","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2020.02.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000117","article-title":"Copy number analysis reveals a novel multiexon deletion of the colq gene in congenital myasthenia","author":"Wang","year":"2016","journal-title":"Neurol Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:29Z","timestamp":1760774969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620300353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0960896620300353"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.02.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A late-onset congenital myasthenic syndrome due to a heterozygous DOK7 mutation","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}